HeartSciences Inc. (HSCSW) Return on equity 2023–2026
HeartSciences Inc. (HSCSW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-4044.0%FY2026 · since FY2023: -2756.1% → -4044.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -4044.0% | +228.2 pp |
| FY2025 | -4272.2% | -4181.9 pp |
| FY2024 | -90.3% | +2665.8 pp |
| FY2023 | -2756.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More HSCSW financial trends
HSCSW RevenueHSCSW Net incomeHSCSW Net marginHSCSW Gross profitHSCSW Gross marginHSCSW Operating incomeHSCSW Operating marginHSCSW Operating cash flowHSCSW Free cash flowHSCSW Capital expendituresHSCSW Stock buybacksHSCSW Dividends paidHSCSW Total assetsHSCSW Total liabilitiesHSCSW Shareholders’ equityHSCSW overview →